Accelerate Diagnostics, Inc Stock Agreements
10 Contracts & Agreements
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 31, 2023)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 14, 2022)
- 2020 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on April 8, 2020)
- Description of our Capital Stock Registered Pursuant to Section 12 of the Securties Exchange Act of 1934 (Filed With SEC on February 28, 2020)
- Nonqualified Stock Option Agreement between Accelerate Diagnostics, Inc. and John J. Phillips, dated August 6, 2019 (Filed With SEC on August 8, 2019)
- Specimen Common Stock Certificate (Filed With SEC on March 1, 2019)
- 2019 Salary Waiver and Nonqualified Stock Option Grant Plan (Filed With SEC on December 28, 2018)
- Forward Stock Purchase Transaction, dated March 22, 2018, between Accelerate Diagnostics, Inc. and JPMorgan Chase Bank, National Association, London Branch (Filed With SEC on March 28, 2018)
- UNDERWRITING AGREEMENT ACCELERATE DIAGNOSTICS, INC. 2,750,000 Shares of Common Stock Underwriting Agreement (Filed With SEC on May 15, 2017)
- UNDERWRITING AGREEMENT ACCELERATE DIAGNOSTICS, INC. 5,588,236 Shares of Common Stock Underwriting Agreement (Filed With SEC on December 15, 2015)
